Ocimum Species as Potential Bioresources against COVID-19: A Review of Their Phytochemistry and Antiviral Activity
Dorothée D. Tshilanda, Etienne M. Ngoyi, Carlos N. Kabengele, Aristote Matondo, Gédéon N. Bongo, Clément L. Inkoto, Clément M. Mbadiko, Benjamin Z. Gbolo, Emmanuel M. Lengbiye, Jason T. Kilembe, Domaine T. Mwanangombo, Giresse N. Kasiama, Damien S. T. Tshibangu, Koto-Te-Nyiwa Ngbolua, Pius T. Mpiana
International Journal of Pathogen Research · pp. 42–54 · Published 27 Nov 2020
10.9734/ijpr/2020/v5i430143Abstract
Aim: The aim of this work was to review literature data reported on some species of the Ocimum genus regarding their phytochemistry and antiviral potential in order to show how Ocimum species might be used in the management of COVID-19. Methodology: Various databases like PubMed, PubMed Central., Science Direct, SCIELO, DOAJ, Science alert, Semantic scholar and Google scholar were used. Results: Essential oils and extracts of Ocimum species possess the compounds involved in antiviral activity. In addition, this plant contains certain nutrients which boost the immune system. Ocimum genus displayed antiviral activity against several viruses like Herpes Simplex Virus, Human Immunodeficiency Virus, Infectious Hematopoietic Necrosis Virus, Adenovirus, Enterovirus 71, Parainfluenza virus type 3, Hepatitis C virus, etc. Toxicological data indicated that these plants are safe. Conclusion: Till now, there is no effective treatment of COVID-19. Ethnopharmacology constitutes an alternative approach for the discovery of effective antiviral drugs. The literature survey reveals that Ocimum species exhibit high antiviral activity, and thus can be used as potential bioresources against COVID-19. Molecular docking study of the interaction of some compounds derived from Ocimum species with SARS-CoV-2 protease is in progress in order to identify the potential inhibitors of the virus.
Cited by 17
Riya Bhattacharya, Debajyoti Bose, Quratulain Maqsood · South African Journal of Botany · 2024
Sitesh C. Bachar, Kishor Mazumder, Ritesh Bachar · Frontiers in Pharmacology · 2021
Ramachandran Maduraiveeran, Balakrishna Kedike, Shakila Ramachandran · Acta Tropica · 2025
Pratibha Mishra, Saima Sohrab, Vijay Tripathi · Journal of Herbal Medicine · 2025
Aristote Matondo, Jason T. Kilembe, Etienne M. Ngoyi · International Journal of Pathogen Research · 2021
Olugbemi Tope Olaniyan, Charles O. Adetunji, Gloria E. Okotie · Journal of Reproductive Healthcare and Medicine · 2021
Lina Silva-Trujillo, Elizabeth Quintero-Rueda, Elena E. Stashenko · Molecules · 2022
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
17
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.